@article{61fdd2eac86e4e41be23add4400c7350,
title = "Trends in smoking rates among individuals with serious psychological distress: Analysis of data from a Japanese national survey, 2007–2016",
abstract = "To determine whether the downward trend in the smoking rate over time in Japan differs between individuals with and without serious psychological distress (SPD), we used nationally representative data sets from the 2007, 2010, 2013, and 2016 Comprehensive Survey of Living Conditions of Japan. SPD was defined as a score ≥ 13 on the six-item Kessler Psychological Distress Scale. We conducted multivariate logistic regression analyses including the interaction terms between SPD and survey year. A total 187,685 participants were included. The interaction terms between SPD and survey year among men were significant for 2010 and 2016 but not for 2013. Among women, the interaction terms between SPD and survey year were not significant for any year. In conclusion, we confirmed that the gap in the rate of smoking between men with SPD and those without SPD decreased from 2007 to 2016. Among women, the gap in the smoking rate between those with SPD and those without SPD remained unchanged. Our findings suggest a need for specific support strategies including pharmacological interventions, especially for women smokers with SPD. Further studies are warranted to identify factors contributing to these sex differences.",
keywords = "Disparity, Mental disorders, Psychological distress, Smoking, Tobacco",
author = "Yuji Higuchi and Masaki Fujiwara and Naoki Nakaya and Maiko Fujimori and Yuto Yamada and Riho Wada and Tsuyoshi Etoh and Kyoko Kakeda and Yosuke Uchitomi and Norihito Yamada and Masatoshi Inagaki",
note = "Funding Information: This work was supported by the Japan Society for the Promotion of Science (Japan Society for the Promotion of Science [JSPS] Grant in-Aid for Scientific Research [KAKENHI] JP17K09112). The funding source played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.Yuji Higuchi has nothing to disclose related to this paper. Masaki Fujiwara has received lecture fees from Mochida, Eli Lilly, and Sumitomo Dainippon and personal fees from Iyaku (Medicine and Drug) Journal and Igaku-Shoin outside the submitted work. Kyoko Kakeda has received lecture fees from Mochida outside the submitted work. Norihito Yamada has received grants from Otsuka, Astellas, MSD, Pfizer, and Takeda outside the submitted work; he has also received lecture fees from Otsuka, Astellas, MSD, Pfizer, Meiji, Janssen, Hisamitsu, Sumitomo Dainippon, Mochida, Tsumura, Takeda, Taiho, and UCB Japan outside the submitted work. Masatoshi Inagaki has received grants from Novartis outside the submitted work; he has also received lecture fees from Meiji, Mochida, Takeda, Novartis, Yoshitomi, Pfizer, Eisai, Otsuka, MSD, and Sumitomo Dainippon and personal fees from Technomics. The institution of Masatoshi Inagaki has received grant or research support from Eisai, Astellas, Pfizer, Daiichi-Sankyo, Takeda, and MSD outside the submitted work. The remaining authors have nothing to disclose. Funding Information: This work was supported by the Japan Society for the Promotion of Science (Japan Society for the Promotion of Science [ JSPS ] Grant in-Aid for Scientific Research [KAKENHI] JP17K09112 ). The funding source played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. Funding Information: Yuji Higuchi has nothing to disclose related to this paper. Masaki Fujiwara has received lecture fees from Mochida, Eli Lilly, and Sumitomo Dainippon and personal fees from Iyaku (Medicine and Drug) Journal and Igaku-Shoin outside the submitted work. Kyoko Kakeda has received lecture fees from Mochida outside the submitted work. Norihito Yamada has received grants from Otsuka, Astellas, MSD, Pfizer, and Takeda outside the submitted work; he has also received lecture fees from Otsuka, Astellas, MSD, Pfizer, Meiji, Janssen, Hisamitsu, Sumitomo Dainippon, Mochida, Tsumura, Takeda, Taiho, and UCB Japan outside the submitted work. Masatoshi Inagaki has received grants from Novartis outside the submitted work; he has also received lecture fees from Meiji, Mochida, Takeda, Novartis, Yoshitomi, Pfizer, Eisai, Otsuka, MSD, and Sumitomo Dainippon and personal fees from Technomics. The institution of Masatoshi Inagaki has received grant or research support from Eisai , Astellas , Pfizer , Daiichi-Sankyo , Takeda, and MSD outside the submitted work. The remaining authors have nothing to disclose. Publisher Copyright: {\textcopyright} 2020 Elsevier B.V.",
year = "2020",
month = sep,
doi = "10.1016/j.psychres.2020.113225",
language = "English",
volume = "291",
journal = "Psychiatry Research",
issn = "0165-1781",
publisher = "Elsevier Ireland Ltd",
}
